abstract |
FIELD: biotechnology. n SUBSTANCE: genetic construct of pMitoCas9 with SEQ ID NO:1 based on the CRISPR/Cas9 genome editing system is obtained, which encodes the cas9 nuclease, specifically imported into human mitochondria. n EFFECT: invention provides efficient synthesis of modified Cas9 nuclease in human cells. n 2 dwg |